Search Login Register

Ehlers-Danlos Syndrome (Syndrome, Ehlers-Danlos) Summary

Description: A heterogeneous group of autosomally inherited COLLAGEN DISEASES caused by defects in the synthesis or structure of FIBRILLAR COLLAGEN. There are numerous subtypes: classical, hypermobility, vascular, and others. Common clinical features include hyperextensible skin and joints, skin fragility and reduced wound healing capability.

Also Known As: Syndrome, Ehlers-Danlos; Ehlers-Danlos Disease; Ehlers-Danlos Syndrome, Type IV; Ehlers-Danlos Syndrome, Vascular Type; Disease, Ehlers-Danlos Show All >>

Networked: 722 relevant articles (5 outcomes, 40 trials/studies) for this Disease

Key Drugs and Agents for Ehlers-Danlos Syndrome

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Collagen : 1 outcome 18 studies in 232 results : IBA
  2. Ascorbic Acid (Vitamin C) : 1 outcome in 3 results : FDA 18 Generic
  3. Doxycycline (Vibramycin) : 1 outcome in 2 results : FDA 23 Generic
  4. Vitamin K : 1 outcome in 1 result : FDA 6
  5. Ubiquinone : 1 outcome in 1 result : IBA
  6. Tramadol : 1 outcome in 1 result : FDA 28 Generic
  7. Silicon Dioxide (Sand) : 1 outcome in 1 result : FDA 1 Generic
  8. Magnesium : 1 outcome in 1 result : IBA
  9. Glucosamine (Dona) : 1 outcome in 1 result : IBA
  10. Carnitine (L-Carnitine) : 1 outcome in 1 result : FDA 9 Generic
Show All >>

Diseases Related to Ehlers-Danlos Syndrome

  1. Varicose Veins (Varicose Vein)
  2. Pain (Aches)
  3. Osteogenesis Imperfecta (Lobstein Disease)
  4. Cutis Laxa
  5. Ehlers-Danlos Syndrome (Syndrome, Ehlers-Danlos)
Show All >>

Key Therapies for Ehlers-Danlos Syndrome

Efficacy Chart >>
  1. Laser Therapy (Surgery, Laser) : 1 outcome in 1 result
  2. Sclerotherapy : 1 outcome in 1 result
  3. Anesthesia : 11 results
  4. Transplants (Transplant) : 10 results
  5. Cesarean Section (Caesarean Section) : 8 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.